You just read:

HEMA Biologics, LLC announced today the acceptance by U.S. Food and Drug Administration of the submitted Biologic License Application for Coagulation Factor VIIa Recombinant, (eptacog beta activated)

News provided by

HEMA Biologics, LLC

Jan 09, 2017, 09:00 ET